Main > PEDIATRICS > Pneumology > Respiratory Distress Syndrome > Treatment > Surfactants. > PorActant Alfa > NonGeneric PorActant Alfa > Patent. > Claims > Claim 1: Animal Lung Surfactant: > a) Polar PhosphoLipids (98.5-99%);



a) Polar PhosphoLipids (98.5-99%);'s subsections
PhosphatidylCholine (>70-75%)

a) Polar PhosphoLipids (98.5-99%);'s products
This section has no products